Loading...
•
Jun 30, 2020
DexCom Q2 2020 Earnings Report
DexCom's revenue increased driven by volume growth and new patient additions.
Key Takeaways
DexCom reported a strong second quarter with revenue growth of 34% compared to the same quarter of the prior year, reaching $451.8 million. GAAP operating income was $67.8 million, representing 15.0% of revenue, and GAAP net income was $46.3 million, or $0.48 per diluted share. The company reinstated its 2020 revenue guidance to approximately $1.850 billion.
Revenue grew 34% versus the same quarter of the prior year to $451.8 million.
U.S. revenue growth of 38% and international revenue growth of 21%.
GAAP operating income of $67.8 million or 15.0% of revenue.
Strengthened balance sheet with successful $1.2 billion convertible note offering.
Revenue by Geographic Location
Forward Guidance
The company is reinstating guidance for fiscal year 2020 revenue, gross profit, operating margin, and Adjusted EBITDA margin as follows:
Positive Outlook
- Revenue of approximately $1.850 billion (25% growth)
- Non-GAAP Gross profit margin to meet or exceed 65%
- Non-GAAP Operating margin to meet or exceed 14%
- Adjusted EBITDA margin to meet or exceed 24%
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...